|
MIER1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.594960E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.095500E-02 |
| Normal-vs-Stage2 |
8.688000E-01 |
| Normal-vs-Stage3 |
8.643800E-02 |
| Normal-vs-Stage4 |
8.487400E-01 |
| Stage1-vs-Stage2 |
4.575400E-01 |
| Stage1-vs-Stage3 |
4.560400E-01 |
| Stage1-vs-Stage4 |
6.572400E-01 |
| Stage2-vs-Stage3 |
2.696400E-01 |
| Stage2-vs-Stage4 |
9.356000E-01 |
| Stage3-vs-Stage4 |
4.435200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.396610E-01 |
| Normal-vs-AfricanAmerican |
2.311800E-01 |
| Normal-vs-Asian |
3.782000E-02 |
| Caucasian-vs-AfricanAmerican |
9.561400E-01 |
| Caucasian-vs-Asian |
4.826600E-01 |
| AfricanAmerican-vs-Asian |
4.521000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.867570E-01 |
| Normal-vs-Female |
2.721200E-01 |
| Male-vs-Female |
9.856400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.430500E-02 |
| Normal-vs-Extreme_Weight |
1.412010E-01 |
| Normal-vs-Obese |
6.157200E-01 |
| Normal-vs-Extreme_Obese |
4.096400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.459200E-01 |
| Normal_Weight-vs-Obese |
1.771570E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.297200E-01 |
| Extreme_Weight-vs-Obese |
4.555600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.217800E-01 |
| Obese-vs-Extreme_Obese |
6.442200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.238400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.161200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.796030E-02 |
| Normal-vs-Age(81-100Yrs) |
9.764600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.153400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.099800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.841990E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.211880E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.456200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.806800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.935000E-01 |
| Normal-VS-Type2 PRCC |
5.78369999999495E-05 |
| Normal-VS-KIRP CIMP |
9.438400E-01 |
| Normal-VS-Unclassified PRCC |
7.619000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.09560000000009E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.470600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.475200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.492100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.737720E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.166000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.177300E-03 |
| Normal-vs-N1 |
9.970000E-01 |
| Normal-vs-N2 |
9.508200E-01 |
| N0-vs-N1 |
1.264590E-01 |
| N0-vs-N2 |
3.353000E-01 |
| N1-vs-N2 |
9.533800E-01 |
|
|
